Our study confirms that the PBMC of patients with B-ALL had increased CTLA-4, LAG3, GITR, and TIM-3 expression, but suggests that only the cells overexpressing CTLA-4 and TIM-3 favor leukemic growth. This evidence concerns the gene HAVCR2 and precursor B-cell acute lymphoblastic leukemia.